|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Section of Nutritional Neuroscience, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892-9410
Published, JLR Papers in Press, June 1, 2005. DOI 10.1194/jlr.M500127-JLR200
1 To whom correspondence should be addressed. e-mail: nsalem{at}niaaa.nih.gov
An important question for mammalian nutrition is the relative efficiency of C18 versus C20 essential fatty acids (EFAs) for supporting the tissue composition of n-3 and n-6 pathway end products. One specific question is whether C22 EFAs are made available to tissues more effectively by dietary
-linolenic acid (18:3n-3) and linoleic acid (18:2n-6) or by dietary eicosapentaenoic acid (20:5n-3) and dihomo-
-linolenic acid (20:3n-6). To address this question in a direct manner, four stable isotope compounds were given simultaneously in a novel paradigm. A single oral dose of a mixture of 2H5-18:3n-3, 13C-U-20:5n-3, 13C-U-18:2n-6, and 2H5-20:3n-6 was administered to rats given a defined diet. There was a preferential in vivo conversion of arachidonic acid (20:4n-6) to docosatetraenoic acid (22:4n-6) and of 22:4n-6 to n-6 docosapentaenoic acid (22:5n-6) when the substrates originated from the C18 precursors. However, when the end products docosahexaenoic acid (22:6n-3) or 22:5n-6 were expressed as the total amount in the plasma compartment divided by the dosage, this parameter was 11-fold greater for 20:5n-3 than for 18:3n-3 and 14-fold greater for 20:3n-6 than for 18:2n-6.
Thus, on a per dosage basis, the total amounts of n-3 and n-6 end products accreted in plasma were considerably greater for C20 EFA precursors relative to C18.
Abbreviations: 18:2n-6, linoleic acid; 18:3n-3,
-linolenic acid; 20:4n-6, arachidonic acid; 20:3n-6, dihomo-
-linolenic acid; 22:6n-3, docosahexaenoic acid; 22:5n-6, n-6 docosapentaenoic acid; 20:5n-3, eicosapentaenoic acid; AUC, area under the curve; CE, cholesteryl ester; Cmax, maximal concentration of labeled fatty acids in plasma; Dmax, maximal percentage of dose; EFA, essential fatty acid; Emax, maximal enrichment of labeled fatty acids at maximal concentration; MESSI, multiple simultaneous stable isotope; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PI, phosphatidylinositol; PL, phospholipid; TG, triglyceride; Tmax, sampling time at maximal concentration
Supplementary key words stable isotope tracer
-linolenic acid eicosapentaenoic acid docosahexaenoic acid linoleic acid dihomo-
-linolenic acid arachidonic acid gas chromatography-mass spectrometry multiple simultaneous stable isotopes
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. H. Lin and N. Salem Jr. Whole body distribution of deuterated linoleic and {alpha}-linolenic acids and their metabolites in the rat J. Lipid Res., December 1, 2007; 48(12): 2709 - 2724. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Stark, S.-Y. Lim, and N. Salem Jr. Artificial rearing with docosahexaenoic acid and n-6 docosapentaenoic acid alters rat tissue fatty acid composition J. Lipid Res., November 1, 2007; 48(11): 2471 - 2477. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Lin, R. J. Pawlosky, and N. Salem Jr. Simultaneous quantitative determination of deuterium- and carbon-13-labeled essential fatty acids in rat plasma J. Lipid Res., September 1, 2005; 46(9): 1974 - 1982. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |